TNF-α promoter polymorphism in relation to TNF-α production and clinical status in cystic fibrosis

Lung

Volumn 184, Issue 2, 2006, Pages 99-104

  Schmitt Grohé, Sabina ^a,c   Stüber, Frank ^a   Book, Malte ^a   Bargon, Joachim ^b   Wagner, Thomas O ^b   Naujoks, Christian ^a   Schubert, Ralf ^b   Lentze, Michael J ^a   Zielen, Stefan ^b  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cystic fibrosis; Diabetes mellitus; FEV1; TNF plasma levels; TNF promoter polymorphism

Indexed keywords

LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ALLELE; ARTICLE; BACTERIAL INFECTION; BODY MASS; CHEMOLUMINESCENCE; CHILD; CORRELATION ANALYSIS; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOSITY; HUMAN; INCIDENCE; LUNG FUNCTION; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; RANK SUM TEST; REAL TIME POLYMERASE CHAIN REACTION; STIMULATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; GENOTYPE; HUMANS; INFANT; LIPOPOLYSACCHARIDES; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); PSEUDOMONAS INFECTIONS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33646000799     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00408-005-2568-x     Document Type: Article

References (26)

1. Arkwright PD, Pravica V, Geraghty PJ, et al. (2003) End-organ dysfunction in cystic fibrosis. Association with angiotensin I converting enzyme and cytokine gene polymorphisms. Am J Respir Crit Care Med 167:384-389
2. Borgo G, Mastella F, Gasparini P, et al. (1990) Pancreatic function and gene deletion F 508 in cystic fibrosis. J Med Genet 27:665-669
3. Campbell PW, Phillips JA, Krishnamani MR, Maness KJ, Hazinski TA (1991) Cystic fibrosis: relationship between clinical status and delta F 508 deletion. J Pediatr 118:239-241
4. Cuenca J, Cuchacovich M, Perez C, et al. (2003) The -308 polymorphism in the tumour necrosis factor (TNF) gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology 42(2):308-313
5. Elborn JS, Cordon SM, Western PJ, Madonald IA, Shale DJ (1993) Tumour necrosis factor-alpha, resting energy expenditure and cachexia in cystic fibrosis. Clin Sci 85(5):563-568
6. Feinstein R, Kanety H, Papa MZ, Lunenfeld B, Karasik A (1993) A tumour necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem 268:26055-26058
7. Greally P, Hussein MJ, Cook AJ, et al. (1993) Sputum tumour necrosis factor-α and leukotriene concentrations in cystic fibrosis. Arch Dis Child 68:389-392
8. Heesen M, Kunz D, Bachmann-Mennenga B, Merk HF, Bloemeke B (2003) Linkage disequilibrium between tumor necrosis factor (TNF)-alpha-308 G/A promoter and TNF-beta NcoI polymorphisms: Association with TNF-α response of granulocytes to endotoxin stimulation. Crit Care Med 31(1):211-214
9. Höhler T, Kruger A, Gerken F, et al. (1998) A tumour necrosis factor-alpha (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol 111:579-582
10. House D, Chinh NT, Hien TT, et al. (2002) Cytokine release by lipopolysaccharide-stimulated whole blood from patients with typhoid fever. J Infect Dis 186(2):240-245
11. Huizenga TW, Westendorp RG, Bollene EL, et al. (1997) TNF-α promoter polymorphisms, production and susceptibility to multiple sclerosis in different groups of patients. J Neuroimmunol 72(2):149-153
12. Hull J, Thomson AH (1998) Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis. Thorax 53:1018-1021
13. Ionescu AA, Nixon LS, Evans WD, et al. (2000) Bone density, body composition, and inflammatory status in cystic fibrosis. Am J Respir Crit Care Med 162:789-794
14. Jacob CO, Fronek Z, Lewis GD, et al. (1990) Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor α: Relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87:1233-1237
15. Johansen HK, Nir M, Hoiby N, Koch C, Schwartz M (1991) Severity of cystic fibrosis in patients homozygous and heterozygous for delta F508 mutation. Lancet 337:631-634
16. Kerem E, Corey M, Kerem BS, et al. (1990) The relation between genotype and phenotype in cystic fibrosis - analysis of the most common mutation (delta F508). N Engl J Med 323:1517-1522
17. Koch M, Rett K, Volk A, et al. (2000) The tumour necrosis factor alpha -238 G → A and -308 G → A promoter polymorphisms are not associated with insulin sensitivity and insulin secretion in young healthy relatives of type II diabetic patients. Diabetologia 43:181-184
18. Konstan MW, Hilliard KA, Norvell TM, Berger M (1994) Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation. Am J Respir Crit Care Med 150(2):448-454
19. Koss K, Satsangi J, Fanning GC, Welsh KI, Jewell DP (2000) Cytokine (TNF-α, LT alpha and IL-10) polymorphisms in inflammatory bowel diseases and normal controls: differential effects on production and allele frequencies. Genes Immun 1(3):185-190
20. Kroeger KM, Carville KS, Abraham LJ (1997) The -308 tumour necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 34(5):391-399
21. Maurer M, Kruse N, Giess R, et al. (1999) Gene polymorphism at position -308 of the tumor necrosis factor alpha promoter is not associated with disease progression in multiple sclerosis. J Neurol 246(10):949-954
22. Norman D, Elborn JS, Cordon SM, et al. (1991) Plasma tumour necrosis alpha in cystic fibrosis. Thorax 46:91-95
23. Santis G, Osborne L, Knight RA, Hodson ME (1990) Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet 336:1081-1084
24. Somoskövi A, Zissel G, Seitzer U (1999) Polymorphisms at position -308 in the promoter region the TNF-α and in the first intron of the TNF-β genes and spontaneous and lipolpolysaccaride-induced TNF-α release in sarcoidosis. Cytokine 11(11):882-887
25. Stuber F, Udalova IA, Book M, et al. (1995-96) -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflamm 46(1):42-50
26. Westendorp RG, Langermans JA, Huizinga TW, et al. (1997) Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349(9046):170-173